Floyd Robert Michael 4
4 · Processa Pharmaceuticals, Inc. · Filed Oct 11, 2022
Insider Transaction Report
Form 4
Floyd Robert Michael
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2022-10-06−4,163→ 72,267 total - Exercise/Conversion
Common Stock
2022-10-06+12,500→ 76,430 total
Holdings
- 89,794(indirect: by Elion Oncology, Inc.)
Common Stock
Footnotes (1)
- [F1]Vesting of restricted stock.